Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
News & Press: Breaking News

IACP Comments on FDA's "Adverse Event Reporting for Outsourcing Facilities Under Section 503B"

Tuesday, May 19, 2015   (0 Comments)
Posted by: Dagmar Anderson
Share |

The International Academy of Compounding Pharmacists (IACP) has submitted comments today to the Food & Drug Administration (FDA) on its "Adverse Event Reporting for Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act" draft guidance.

 

Please click here to read IACP's comments in their entirety.


Association Management Software Powered by YourMembership.com®  ::  Legal